DH065ZZ
Beam Radiation Skin, Chest to None with None, Neutrons Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | H Skin |
| Operation | 0 Beam Radiation |
| Body Part | 6 Skin, Chest |
| Approach | 5 Neutrons |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Beam radiation to the skin uses an external machine to aim ionizing radiation, typically low-energy or superficial x-rays or electron beams, directly at a lesion or area on the skin's surface. It is a common treatment for basal cell and squamous cell skin cancers, particularly on the face, scalp, or other areas where surgical removal would be difficult or disfiguring, and it is also used for Kaposi sarcoma lesions, keloid scars, and certain benign but symptomatic skin conditions.
Because the beam can be focused to a shallow depth, it damages the targeted skin cells while limiting exposure to deeper tissue. Treatment is usually delivered in a series of short outpatient sessions over one to several weeks, with the total dose divided into fractions to reduce side effects such as skin redness, dryness, or peeling in the treated area.
Anatomy & Axis Detail
Skin, Chest
Chest skin is targeted with beam radiation for cutaneous malignancies, mycosis fungoides and other cutaneous lymphomas, or postmastectomy chest wall recurrences, and its proximity to the underlying lungs and heart makes this one of the more anatomically sensitive skin sites for external beam planning. Treatment fields must account for respiratory motion and often use bolus material to ensure adequate surface dose while limiting penetration into thoracic structures. Chest skin involvement frequently arises in the context of breast cancer recurrence after mastectomy, where the skin itself, rather than residual breast tissue, becomes the primary treatment target. Accurate coding depends on distinguishing beam radiation to the skin surface from radiation directed at deeper chest wall or breast tissue documented elsewhere in the record.
Modality Qualifier: Neutrons
Neutrons refers to fast neutron radiotherapy, a technique with a higher linear energy transfer than photons or electrons, producing greater biological effectiveness per unit dose. It is reserved for select radioresistant tumors, such as some salivary gland malignancies, where conventional photon therapy has historically underperformed. It is distinct from Neutron Capture, which relies on a separate boron-uptake mechanism rather than direct neutron beam irradiation.
Coding & Documentation
Coding from this family requires documentation of the specific skin site treated and confirmation that an external beam device, not a topical or implanted source, delivered the radiation. The treatment planning note and daily treatment records should specify the anatomical region, since ICD-10-PCS distinguishes skin sites by general body area rather than by exact lesion location. A common mistake is coding each treatment fraction separately when the payer or facility policy calls for a single code representing the full course, or conversely failing to capture repeat courses when a lesion recurs and is treated again later. Coders should also watch for cases where a dermatologic radiation unit uses superficial or contact-style equipment, which may fall under the Other Radiation qualifier rather than Beam Radiation, so the equipment type documented in the treatment record needs to be checked rather than assumed.
Commonly Confused With
The closest source of confusion is D|H|Y (Other Radiation to the skin), which covers modalities such as contact or plesiotherapy units, superficial isotope applicators, or other non-beam techniques; the distinguishing detail is the type of radiation-generating equipment used, found in the radiation oncology treatment plan. It can also be confused with dermatologic procedures coded outside the Radiation Therapy section, such as cryotherapy or laser destruction of skin lesions, which use non-ionizing energy sources and are not radiation therapy at all despite treating similar lesions.